Synchronous and metachronous carcinoma of the breast.
Synchronous and metachronous carcinoma of the breast.
复制标题
乳腺癌的同步和异时癌。
DOI：
10.1097/00006534-198207000-00058
复制
发表时间：
1982
期刊：
影响因子：
3.8
通讯作者：
T. Gaffey
中科院分区：
文献类型：
--
作者：
J. Martin;J. V. van Heerden;T. Gaffey
为了确定同步双侧乳腺癌的发病率，100名接受原发性乳腺癌初始治疗的妇女前瞻性地对侧乳房进行了活检。没有患者在对侧乳房有临床可检测到的异常，但2%的患者有未被怀疑的浸润性导管癌。另有5%的患者有癌前病变。为了确定异时性乳腺癌的发病率，我们对1955年至1979年间接受手术治疗的153例原发性乳腺癌患者进行了为期2个月至26年的随访，平均随访3.6年。在此期间，3.9%的患者发生对侧乳腺异时性癌。
To determine the incidence of synchronous bilateral breast cancer, 100 women receiving their initial treatment for primary breast cancer prospectively underwent biopsy of the opposite breast. No patient had a clinically detectable abnormality in the contralateral breast, but 2% had unsuspected invasive ductal carcinomas. An additional 5% had premalignant lesions. To determine the incidence of the development of metachronous breast cancer, 153 women who underwent surgical treatment of primary breast cancer between 1955 and 1979 were followed from 2 months to 26 years, with an average of 3.6 years. During that time, 3.9% developed metachronous carcinomas of the contralateral breast.